Indications of lymphatic endothelial differentiation and endothelial progenitor cell activation in the pathology of proliferative diabetic retinopathy

Acta Ophthalmologica

Volumn 93, Issue 6, 2015, Pages 512-523

  Loukovaara, Sirpa ^a   Gucciardo, Erika ^a   Repo, Pauliina ^a   Vihinen, Helena ^c   Lohi, Jouko ^b   Jokitalo, Eija ^c   Salven, Petri ^b   Lehti, Kaisa ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

angiogenesis; electron microscopy; endothelial cell; lymphangiogenesis; proliferative diabetic retinopathy; stem cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CELL PROTEIN; ETS RELATED GENE PROTEIN; KI 67 ANTIGEN; LYMPHATIC VESSEL ENDOTHELIAL RECEPTOR 1 PROTEIN; NG2 PROTEIN; PODOPLANIN; PROSPERO RELATED HOMEOBOX GENE 1 PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3; ACTA2 PROTEIN, HUMAN; ACTIN; BIOLOGICAL MARKER; DNA BINDING PROTEIN; ETV5 PROTEIN, HUMAN;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIAL PROGENITOR CELL; GENE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH VESSEL ENDOTHELIUM; LYVE 1 GENE; MACROPHAGE; MICROGLIA; PDPN GENE; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROX 1 GENE; TISSUE DIFFERENTIATION; CELL DIFFERENTIATION; DIABETIC RETINOPATHY; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RETINAL NEOVASCULARIZATION; VITRECTOMY;

ACTINS; ANTIGENS, CD31; BIOMARKERS; CELL DIFFERENTIATION; DIABETIC RETINOPATHY; DNA-BINDING PROTEINS; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIUM, LYMPHATIC; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MICROSCOPY, ELECTRON; PROTO-ONCOGENE PROTEINS C-KIT; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL NEOVASCULARIZATION; TRANSCRIPTION FACTORS; VITRECTOMY;

EID: 84947036307     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12741     Document Type: Article

References (67)

1. Abu El-Asrar AM, Struyf S, Opdenakker G, van Damme J, &, Geboes K, (2010): Expression of stem cell factor/c-kit signaling pathway components in diabetic fibrovascular epiretinal membranes. Mol Vis 16: 1098-1107.
2. Adamis AP, (2002): Is diabetic retinopathy an inflammatory disease? B J Ophthalmol 86: 363-365.
3. Adamis AP, &, Berman AJ, (2008): Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol 30: 65-84.
4. Alitalo K, (2011): The lymphatic vasculature in disease. Nat Med 17: 1371-1380.
5. Antonetti DA, Barber AJ, Bronson SK, et al., (2006): Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 55: 2401-2411.
6. Anttonen T, Belevich I, Kirjavainen A, Laos M, Brakebusch C, Jokitalo E, &, Pirvola U, (2014): How to bury the dead: elimination of apoptotic hair cells from the hearing organ of the mouse. J Assoc Res Otolaryngol 15: 975-992.
7. Aspelund A, Tammela T, Antila S, et al., (2014): The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel. J Clin Invest 124: 3975-3986.
8. Baluk P, &, McDonald DM, (2008): Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann NY Acad Sci 1131: 1-12.
9. Bock F, Onderka J, Dietrich T, Bachmann B, Kruse FE, Paschke M, Zahn G, &, Cursiefen C, (2007): Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis. Invest Ophthalmol Vis Sci 48: 2545-2552.
10. Breiteneder-Geleff S, Soleiman A, Kowalski H, et al., (1999): Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154: 385-394.
11. Chambers SEJ, ONeill CL, ODoherty M, Medina RJ, &, Stitt AW, (2013): The role of immune-related myeloid cells in angiogenesis. Immunobiology 218: 1370-1375.
12. Checchin D, Sennlaub F, Levavasseur E, Leduc M, &, Chemtob S, (2006): Potential role of microglia in retinal blood vessel formation. Invest Ophthalmol Vis Sci 47: 3595-3602.
13. Costa C, Incio J, &, Solares R, (2007): Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 10: 149-166.
14. Cursiefen C, Schlotzer-Schrehardt U, Kuchle M, et al., (2002): Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci 43: 2127-2135.
15. Cursiefen C, Chen L, Dana MR, &, Streilein JW, (2003): Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology. Cornea 22: 273-281 Review.
16. Cursiefen C, Chen L, Borges LP, et al., (2004): VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113: 1040-1050.
17. Demircan N, Safran BG, Soylu M, Ozcan A, &, Sizmaz S, (2006): Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye 20: 1366-1369.
18. Detry B, Ericum J, Paupert J, et al., (2012): Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase. Blood 119: 5048-5056.
19. Dorrell M, Uusitalo-Järvinen H, Aguilar E, &, Friedlander M, (2007): Ocular neovascularization: basic mechanisms and therapeutic advances. Surv Ophthalmol 52 (Suppl1): S3-S19.
20. Epstein DL, Algvere PV, von WG, Seregard S, &, Kvanta A, (2012): Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study. Ophthalmology 119: 2587-2591.
21. Fang S, &, Salven P, (2011): Stem cells in tumor angiogenesis. J Mol Cell Cardiol 50: 290-295.
22. Fang S, Wei J, Pentinmikko N, Leinonen H, &, Salven P, (2012): Generation of functional blood vessels from a single c-kit+ adult vascular endothelial stem cell. PLoS Biol 10: e1001407.
23. Fiedler U, Reiss Y, Scharpfenecker M, et al., (2006): Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation. Nat Med 12: 235-239.
24. Folkman J, (1971): Tumor angiogenesis: therapeutic implications. N Engl J Med 18: 289 1182-6.
25. Forrester JV, (2013): Bowman lecture on the role of inflammation in degenerative disease of the eye. Eye 27: 340-352.
26. Friedlander M, (2007): Fibrosis and diseases of the eye. J Clin Invest 117: 576-586.
27. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, &, Levison SW, (2002): Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 47 (Suppl 2): S253-S262.
28. Goligorsky MS, &, Salven P, (2013): Concise review: endothelial stem and progenitor cells and their habitats. Stem Cells Transl Med 2: 499-504.
29. Grimaldo S, Garcia M, Zhang H, &, Chen L, (2010): Specific role of lymphatic marker podoplanin in retinal pigment epithelial cells. Lymphology 43: 128-134.
30. Gustavsson C, Agardh CD, &, Agardh E, (2013): Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy. Acta Ophthalmol 91: 445-452.
31. Hägerling R, Pollmann C, Andreas M, et al., (2013): A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy. EMBO J 32: 629-644.
32. Heindl LM, Hofmann TN, Knorr HL, et al., (2009): Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension. Invest Ophthalmol Vis Sci 50: 1988-1995.
33. Heindl LM, Hofmann TN, Adler W, Knorr HL, Holbach LM, Naumann GO, (2010): Intraocular tumor-associated lymphangiogenesis: a novel prognostic factor for ciliary body melanomas with extraocular extension? Ophthalmology 117: 334-342.
34. Heindl LM, Hofmann-Rummelt C, Adler W, Bosch JJ, Holbach LM, Naumann GO, Kruse FE, &, Cursiefen C, (2011): Tumor-associated lymphangiogenesis in the development of conjunctival melanoma. Invest Ophthalmol Vis Sci 52: 7074-7083.
35. Hong YK, Harvey N, Noh YH, Schacht V, Hirakawa S, Detmar M, &, Oliver G, (2002): Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 225: 351-357.
36. Hos D, &, Cursiefen C, (2014): Lymphatic vessels in the development of tissue and organ rejection. Adv Anat Embryol Cell Biol 214: 119-141.
37. Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, &, Yoder MC, (2005): Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105: 2783-2786.
38. Ji R-C, (2014): Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis. J Can Lett 346: 6-16.
39. Joussen AM, Poulaki V, Qin W, et al., (2002): Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitrix oxide synthase expression and initiates early diabetic retinal leucocyte adhesion in vivo. Am J Pathol 160: 501-509.
40. Joussen AM, Poulaki V, Le ML, et al., (2004): A central role for inflammation in the pathogenesis of diabetic retinopathy. Faseb J 18: 1450-1452.
41. Kiefer F, &, Adams RH, (2008): Lymphatic endothelial differentiation: start out with Sox-carry on with Prox. Genome Biol 9: 243.
42. Kurihara T, Westenskow PD, Bravo S, Aguilar E, &, Friedlander M, (2012): Targeted deletion of Vegfa in adult mice induces vision loss. J Clin Invest 122: 4213-4217.
43. Lois N, McCarter RV, ONeill C, Medina RJ, &, Stitt AW, (2014): Endothelial progenitor cells in diabetic retinopathy. Front Endocrinol 44: 1-11.
44. Loukovaara S, Robciuc A, Holopainen JM, et al., (2013): Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes under-going vitrectomy. Acta Ophthalmol 91: 531-539.
45. Mäkinen T, Norrmen C, &, Petrova TV, (2007): Molecular mechanisms of lymphatic vascular development. Cell Mol Life Sci 64: 1915-1929.
46. Medzhitov R, (2008): Origin and physiological roles of inflammation. Nature 454: 428-435.
47. Nakao S, Hafezi-Moghadam A, &, Ishibashi T, (2012): Lymphatics and lymphangiogenesis in the eye. J Ophthalmol 2012: 783163.
48. Noda K, Nakao S, Ishida S, &, Ishibashi T, (2012): Leukocyte adhesion molecules in diabetic retinopathy. J Ophthalmol 2012: 279037.
49. Park D-Y, Lee J, Park I, Choi D, et al., (2014): Lymphatic regulator PROX1 determines Schlemm canal integrity and identity. J Clin Invest 124: 3960-3974.
50. Petrova TV, Mäkinen T, Mäkelä TP, et al., (2002): Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 21: 4593-4599.
51. Pytowski B, Goldman J, Persaud K, et al., (2005): Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 97: 14-21.
52. Ran S, &, Montgomery KE, (2012): Macrophage-mediated lymphangiogenesis: the emerging role of macrophages as lymphatic endothelial progenitors. Cancers 4: 618-657.
53. Sakurai E, Anand A, Ambati BK, van Rooijen N, &, Ambati J, (2003): Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44: 3578-3585.
54. Schlereth SL, Neuser B, Caramoy A, Grajewski RS, Koch KR, Schrödl F, Cursiefen C, &, Heindl LM, (2014): Enrichment of lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1)-positive macrophages around blood vessels in the normal human sclera. Invest Ophthalmol Vis Sci 13: 13453.
55. Sebzda E, Hibbard C, Sweeney S, et al., (2006): yk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development. Dev Cell 11: 349-361.
56. Shimoda H, (2009): Immunohistochemical demonstration of Angiopoietin-2 in lymphatic vascular development. Histochem Cell Biol 131: 231-238.
57. Tammela T, Zarkada G, Wallgard E, et al., (2008): Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454: 656-659.
58. Teijeira A, Rouzaut A, &, Melero I, (2013): Initial afferent lymphatic vessels controlling outbound leukocyte traffic from skin to lymph nodes. Front in Immunol 4: 433 1-14.
59. Valtola R, Salven P, Heikkilä P, et al., (1999): VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 154: 1381-1390.
60. Wessel JM, Hofmann-Rummelt C, Kruse FE, Cursiefen C, &, Heindl LM, (2012): Invasion of lymphatic vessels into the eye after open globe injuries. Invest Ophthalmol Vis Sci 53: 3717-3725.
61. Wynn TA, (2007): Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 117: 524-529.
62. Xu H, Chen M, Mayer EJ, Forrester JV, &, Dick AD, (2007a): Turnover of resident retinal microglia in the normal adult mouse. Glia 55: 1189-1198.
63. Xu H, Chen M, Reid DM, &, Forrester JV, (2007b): LYVE positive macrophages are present in normal murine eyes. Invest Ophthalmol Vis Sci 48: 2162-2170.
64. Xu H, Chen M, &, Forrester JV, (2009): Para-inflammation in the aging retina. Prog Ret Eye Res 28: 348-368.
65. Yan Z-X, Jiang Z-H, &, Liu N-F, (2012): Angiopoietin-2 promotes inflammatory lymphangiogenesis and its effect can be blocked by specific inhibitor L1-10. Am J Physiol Heart Circ Physiol 302: H215-H223.
66. Zheng W, Aspelund A, &, Alitalo K, (2014): Lymphangiogenic factors, mechanisms, and applications. J Clin Invest 124: 878-887.
67. Zhou J, Wang S, &, Xia X, (2012): Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Curr Eye Res 37: 416-420.